StockData
Absci Corp logo

Absci Corp (ABSI) stock

ABSINasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$8.18+0.60 (+7.92%)

Close on Nov 18, 2026Market cap $1.40BP/E –Yield –

Absci operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Absci's operating income for the twelve months ending Jun 30, 2026 was -$126.20M. For fiscal 2025 it was -$120.32M. The highest annual figure on record is -$13.30M in fiscal 2020.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$120.32M–
FY2024Dec 31, 2024-$108.89M–
FY2023Dec 31, 2023-$115.52M–
FY2022Dec 31, 2022-$106.75M–
FY2021Dec 31, 2021-$75.24M–
FY2020Dec 31, 2020-$13.30M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$34.16M–
Q1 FY2026Mar 31, 2026-$30.85M–
Q4 FY2025Dec 31, 2025-$31.04M–
Q3 FY2025Sep 30, 2025-$30.15M–
Q2 FY2025Jun 30, 2025-$31.39M–
Q1 FY2025Mar 31, 2025-$27.73M–
Q4 FY2024Dec 31, 2024-$29.77M–
Q3 FY2024Sep 30, 2024-$28.90M–
Q2 FY2024Jun 30, 2024-$26.72M–
Q1 FY2024Mar 31, 2024-$23.50M–
Q4 FY2023Dec 31, 2023-$24.74M–
Q3 FY2023Sep 30, 2023-$23.30M–
Q2 FY2023Jun 30, 2023-$42.99M–
Q1 FY2023Mar 31, 2023-$24.49M–
Q4 FY2022Dec 31, 2022-$21.09M–
Q3 FY2022Sep 30, 2022-$27.97M–
Q2 FY2022Jun 30, 2022-$28.89M–
Q1 FY2022Mar 31, 2022-$28.80M–
Q4 FY2021Dec 31, 2021-$26.26M–
Q3 FY2021Sep 30, 2021-$21.14M–
Q2 FY2021Jun 30, 2021-$16.69M–
Q1 FY2021Mar 31, 2021-$11.15M–
Q4 FY2020Dec 31, 2020-$4.63M–
Q3 FY2020Sep 30, 2020-$3.36M–
Q2 FY2020Jun 30, 2020-$2.81M–

More Absci figures

See a number that looks wrong?